When serology misleads: cross-reactivity in acute hepatitis
Open Access
- 5 December 2025
- journal article
- review article
- Published by Springer Nature in Archives of Virology
- Vol. 171 (1) , 12
Abstract
Acute viral hepatitis (AVH) caused by hepatitis A virus (HAV), hepatitis E virus (HEV), Epstein-Barr virus (EBV), and cytomegalovirus (CMV) often presents with similar clinical and biochemical features. However, serological cross-reactivity among these viruses poses significant diagnostic challenges, potentially leading to misclassification, inappropriate management, and unreliable epidemiological data. To review the immunological mechanisms contributing to serological cross-reactivity in AVH and highlight the diagnostic and clinical implications, with a focus on the importance of molecular confirmation. A structured literature review was conducted using the PubMed, EMBASE, Scopus, and Web of Science databases. Keywords included terms related to cross-reactivity, acute hepatitis, serological testing, molecular diagnostics, and specific viral agents. Peer-reviewed studies published in English up to 2025 were included. Cross-reactivity in AVH is primarily driven by polyclonal B-cell activation, antibody polyreactivity, and T-cell receptor cross-specificity. Studies report that up to 33.3% of anti-HEV IgM–positive samples also test positive for EBV or CMV IgM, despite negative PCR confirmation. This overlap is particularly problematic in immunocompromised individuals and pregnant women, where accurate pathogen identification is critical. While PCR offers superior specificity and sensitivity, its implementation is limited by cost and accessibility in low-resource settings. Serological cross-reactivity in acute hepatitis significantly impacts diagnostic precision and clinical decision-making. Incorporating molecular testing, especially PCR, into diagnostic workflows is essential to ensure accurate diagnosis, particularly in high-risk populations.Keywords
This publication has 60 references indexed in Scilit:
- IL‐15‐induced CD38+HLA‐DR+CD8+ T cells correlate with liver injury via NKG2D in chronic hepatitis B cirrhosisClinical & Translational Immunology, 2024
- Biochemical and biophysical characterization of natural polyreactivity in antibodiesCell Reports, 2023
- Epstein-Barr virus: Biology and clinical diseaseCell, 2022
- Analysis of Antigen‐Specific Human Memory B Cell Populations Based on In Vitro Polyclonal StimulationCurrent Protocols in Immunology, 2020
- Epstein-Barr Virus and Cytomegalovirus Infections of the LiverGastroenterology Clinics of North America, 2020
- Innate-like Cytotoxic Function of Bystander-Activated CD8+ T Cells Is Associated with Liver Injury in Acute Hepatitis AImmunity, 2018
- Cytomegalovirus infection in pregnancyBirth Defects Research, 2017
- Reassessing immune control of hepatitis A virusCurrent Opinion in Virology, 2015
- Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infectionJournal of Medical Virology, 2013
- Epstein-barr virus associated acute hepatitis with cross-reacting antibodies to other herpes viruses in immunocompetent patients: Report of two casesJournal of Medical Virology, 2013